| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |